Aigen Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,598	Closed	-$868K	–	538
2025 Q4	$868K	Buy	+14,598	New	+$795K	0.2%	141
2025 Q3	–	Sell	-62,549	Closed	-$3.44M	–	804
2025 Q2	$3.44M	Buy	+62,549	New	+$3.68M	0.47%	30
2023 Q4	–	Sell	-8,691	Closed	-$769K	–	807
2023 Q3	$769K	Buy	8,691 +1,521	+21%	+$135K	0.14%	228
2023 Q2	$621K	Buy	+7,170	New	+$675K	0.09%	295
2022 Q2	–	Sell	-4,763	Closed	-$367K	–	538
2022 Q1	$367K	Sell	4,763 -497	-9%	-$41.6K	0.06%	330
2021 Q4	$446K	Buy	+5,260	New	+$434K	0.03%	670
2021 Q2	–	Sell	-7,317	Closed	-$553K	–	482
2021 Q1	$553K	Buy	+7,317	New	+$598K	0.07%	275
2020 Q2	–	Sell	-1,071	Closed	-$91K	–	847
2020 Q1	$91K	Buy	+1,071	New	+$92.3K	0.01%	879